✦ LIBER ✦

Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study

✍ Scribed by Andreas Böhle; Herbert Leyh; Christian Frei; Michael Kühn; Reinhold Tschada; Tobias Pottek; Walter Wagner; Helmut H. Knispel; Wolfgang von Pokrzywnitzki; Ferruh Zorlu; Karin Helsberg; Birgit Lübben; Victoria Soldatenkova; Clemens Stoffregen; Hartwig Büttner

Book ID: 113611520
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 535 KB
Volume: 56
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2009.06.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SINGLE POSTOPERATIVE INSTILLATION OF GEM

SINGLE POSTOPERATIVE INSTILLATION OF GEMCITABINE IN PATIENTS WITH SUPERFICIAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 MULTICENTER STUDY

✍ Böhle, Andreas; Helsberg, Karin; Soldatenkova, Victoria; Lübben, Birgit; Stoffre 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 51 KB

IS EARLY SINGLE-DOSE INSTILLATION OF EPI

IS EARLY SINGLE-DOSE INSTILLATION OF EPIRUBICIN ABLE TO IMPROVE BCG EFFICACY IN NON-MUSCLE INVASIVE HIGH-RISK BLADDER CANCER PATIENTS? RESULTS FROM A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND AND CONTROLLED STUDY

✍ R. Bartoletti; T. Cai; N. Mondaini; G. Nesi; S. Mazzoli; V. Boddi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A Phase III, Randomized, Double-blind, P

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

✍ Herschorn, Sender; Barkin, Jack; Castro-Diaz, David; Frankel, Jeffrey M.; Espuna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 407 KB

A Phase III, Randomized, Double-blind, P

✍ Rovner, E.S. 📂 Article 📅 2014 🏛 Elsevier Science ⚖ 49 KB

The ACT-ONE trial, a multicentre, random

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

✍ Andrew J. Stewart Coats; Venkatesan Srinivasan; Jayaraman Surendran; Haritha Chi 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 177 KB

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

✍ Lee S. Rosen; David Gordon; N. Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views